Expression of nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) inversely correlates with tumor progression in gastric adenomas and carcinomas

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 9, 2008, Pages 1029-1035

  Park, J Y ^a   Park, K H ^a   Bang, S ^a   Kim, M H ^a   Koh, S S ^b   Song, S Y ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Gastric adenoma; Gastric carcinoma; Nonsteroidal anti inflammatory drug activated gene

Indexed keywords

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; NONSTEROIDAL ANTIINFLAMMATORY DRUG ACTIVATED GENE 1; PRIORITY JOURNAL; STOMACH ADENOMA; STOMACH CARCINOMA; STOMACH EPITHELIUM; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

ADENOMA; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; STOMACH NEOPLASMS;

EID: 49649126456     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0362-x     Document Type: Article

References (24)

1. SJ Baek KS Kim JB Nixon LG Wilson TE Elling 2001 Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities Mol Pharmacol 83 493 501
2. SJ Baek JS Kim SM Moore SH Lee J Martinez TE Elling 2004 Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein Mol Pharmacol 67 356 364
3. AR Bauskin H Zhang WD Fairlie XY He PK Russell AG Moore DA Brown KK Stanley SN Breit 2000 The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-superfamily member, acts as a quality control determinant for correctly folded MIC-1 EMBO J 19 2212 2220
4. AR Bauskin DA Brown T Kuffner H Johnen XW Luo M Hunter SN Breit 2006 Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer Cancer Res 15 4983 4986
5. PF Coogan L Rosenberg JR Palmer BL Strom AG Zauber PD Stolley S Shapiro 2000 Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel Cancer Epidemio Biomarkers Prev 9 119 123
6. A Goel DK Chang L Ricciardiello C Gasche CR Boland 2003 A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells Clin Cancer Res 9 383 390
7. TJ Jang HJ Kang JR Kim CH Yang 2004 Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis Carcinogenesis 25 1853 1858
8. MK Jones H Wang BM Peskar E Levin RM Itani IJ Sarfeh AS Tarnawski 1999 Inhibition of angiogenesis by nonsteroidal antiinflammatory drugs; insight into mechanisms and implications for cancer growth and ulcer healing Nat Med 5 1418 1423
9. ME Kadin MW Cavaillie-Coll R Gertz J Massague S Cheifetz D George 1994 Loss of receptors for transforming growth factor beta in human T-cell malignancies Proc Natl Acad Sci U S A 91 6002 6006
10. IY Kim DH Lee HJ Ahn H Tokunaga W Song LM Devereaux D Jin TK Sampath RA Morton 2000 Expression of bone morphogenetic protein receptors type-IA, -IB and II correlates with tumor grade in human prostate cancer tissues Cancer Res 60 2840 2844
11. K Kim SJ Baek GP Flake CD Loftin BF Calvo TE Eling 2002 Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue Gastroenterology 122 1388 1398
12. GA Kune S Kune LF Watson 1988 Colorectal cancer risk, chronic illness, operation and medications: case control results from the Melbourne Colorectal Cancer Study Cancer Res 48 4399 4404
13. MJ Langman KK Cheng EA Gilman RJ Laucachire 2000 Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database Br Med J 320 1642 1646
14. LN Lawton MF Bonaldo PC Jelenc L Qiu SA Baumes RA Marcelino GM de Jesus S Wellington JA Knowles D Warburton S Brown MB Soares 1997 Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta Gene 203 17 26
15. PX Li J Wong A Ayed D Ngo AM Brade C Arrowsmith RC Austin HJ Klamut 2000 Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression J Biol Chem 275 20127 20135
16. SD Markowitz AB Roberts 1996 Tumor suppressor activity of the TGF-B pathway in human cancers Cytokine Growth Factor Rev 7 93 102
17. RP Pang JG Zhou ZR Zeng XY Li W Chen MH Chen PJ Hu 2007 Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway Cancer Lett 251 268 277
18. VM Paralkar AL Vail WA Grasser TA Brown H Xu S Vukicevic HZ Ke H Qi TA Owen DD Thompson 1998 Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family J Biol Chem 273 13760 13767
19. JY Park KH Park TY Oh SP Hong TJ Jeon CH Kim SW Park JB Chung SY Song S Bang 2007 Up-regulated claudin 7 expression in intestinal-type gastric carcinoma Oncol Rep 18 377 382
20. K Park SJ Kim YJ Bang JG Park NK Kim AB Roberts 1994 Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta Proc Natl Acad Sci U S A 91 8772 8776
21. M Tan Y Wang K Guan Y Sun 2000 PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway Proc Natl Acad Sci U S A 97 109 114
22. R Thomas LD True PH Lange RL Vessella 2001 Placental bone morphogenic protein (PLAB) gene expression in normal, premalignant and malignant human prostate cancer: relation to tumor development and progression Int J Cancer 93 47 52
23. DW Voskuil E Kampman AA van Kraats HF Balder GN van Muijen RA Goldbohm P van't Veer 1999 p53 over-expression and p53 mutations in colon carcinomas: relation to dietary risk factors Int J Cancer 81 675 681
24. Y Yuasa 2003 Control of gut differentiation and intestinal-type gastric carcinogenesis Nat Rev Cancer 3 592 600